Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants

Pediatric Infectious Disease Journal

Volumn 19, Issue 2, 2000, Pages 113-117

  Buckingham, Steven C ^a,b   Bush, Andrew J ^a   Devincenzo, John P ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

Disease severity; Quantitative viral culture; Respiratory failure; Respiratory syncytial virus

Indexed keywords

RIBAVIRIN;

ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ETHNOLOGY; GESTATIONAL AGE; HUMAN; INCIDENCE; NOSE CAVITY; PLAQUE FORMING CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STATISTICAL ANALYSIS; VIRUS INFECTION;

FEMALE; HOSPITALIZATION; HUMANS; INFANT; LINEAR MODELS; MALE; NASAL LAVAGE FLUID; PLAQUE ASSAY; RESPIRATION, ARTIFICIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SEVERITY OF ILLNESS INDEX;

EID: 0033955897     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200002000-00006     Document Type: Article

References (14)

1. Shay DK, Holman RC, Anderson LJ. Bronchiolitis-associated hospitalizations among United States children from 1980 through 1995 [Abstract]. Clin Infect Dis 1998;27:928.
2. Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection: a randomized double-blind study. N Engl J Med 1983; 308:1443-7.
3. Hall CB, McBride J, Gala C, Hildreth SW, Schnabel KC. Ribavirin treatment of respiratory syncytial virus infection in infants with underlying cardiopulmonary disease. JAMA 1985;254:3047-51.
4. Hemming VG, Rodriguez W, Kim HW, et al. Intravenous immune globulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 1987;31:1882-6.
5. Rodriguez WJ, Gruber WC, Welliver RC, et al. Respiratory syncytial virus immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections. Pediatrics 1997;99:454-61.
6. Malley R, DeVincenzo J, Ramilo O, et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1998;178:1555-61.
7. Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus infection: a prospective, double-blind, randomized trial. Crit Care Med 1994;22:566-72.
8. Randolph AG, Wang EE. Ribavirin for respiratory syncytial virus lower respiratory tract infection: a systematic overview. Arch Pediatr Adolesc Med 1996;150:942-7.
9. Hall CB. Respiratory syncytial virus infection in infants: quantitation and duration of shedding. J Pediatr 1976;89:11-15.
10. American Academy of Pediatrics, Committee on Infectious Diseases, Committee on Fetus and Newborn. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IG. Pediatrics 1998;102:1211-16.
11. Scott CL, Iyasu S, Rowley D, Atrash HK. Postneonatal mortality surveillance: United States, 1980-1994. MMWR CDC Surveill Summ 1998;47(SS-2):15-28.
12. Wang EEL, Law BJ, Stephens D, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial virus lower respiratory infection. J Pediatr 1995;126:212-9.
13. Lowther SA, Holman RC, Clark MJ, Kaufman SF, Anderson LJ, Shay DK. Bronchiolitis-associated hospitalization among American Indian and Alaska Native children, 1990 through 1995 [Abstract]. Clin Infect Dis 1998;27:1062.
14. Hall CB, Douglas RG, Geiman JM. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 1975;132:151-6.